コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 V. vulnificus infections were reported to the Centers fo
2 V. vulnificus inoculated into iron dextran-treated mice
3 V. vulnificus is a gram-negative bacterium, considered o
4 V. vulnificus is able to use host iron sources such as h
5 V. vulnificus mutants with varying effector domain conte
6 V. vulnificus strains containing pGTR902 were inoculated
7 V. vulnificus was exposed to structural and vegetation a
8 V. vulnificus wound infections due to seawater exposure
9 V. vulnificus-associated diseases are noted for the rapi
11 shifted northwards 48 km p.a. By 2041-2060, V. vulnificus infections may expand their current range
14 the rtxA1 gene that encodes MARTX(Vv) in 40 V. vulnificus Biotype 1 strains and found four distinct
15 In a survey of the 16S rRNA genotype in 67 V. vulnificus human clinical and nonclinical strains, we
17 thal factor or when naturally delivered as a V. vulnificus MARTX toxin led to loss of mitochondrial m
18 is study, we have cloned and characterized a V. vulnificus type IV pilin (PilA) that shares extensive
19 lated outer membrane protein purified from a V. vulnificus fur mutant had 53% homology with the first
20 Using TnphoA mutagenesis, we identified a V. vulnificus CPS locus, which included an upstream ops
21 sults discussed here confirmed homology of a V. vulnificus CPS locus to the group 1 CPS operon in Esc
24 bacteriophages as therapeutic agents against V. vulnificus in an iron-dextran-treated mouse model of
25 hat estrogen is providing protection against V. vulnificus lipopolysaccharide-induced endotoxic shock
30 antibiotic-resistant V. parahaemolyticus and V. vulnificus, including V. parahaemolyticus pandemic st
31 ains), V. parahaemolyticus (30 strains), and V. vulnificus (10 strains) to determine the accuracy of
35 t hospitalizations and deaths were caused by V. vulnificus infection, and most patients were white me
36 inflammation-mediated septic shock caused by V. vulnificus is strongly associated with liver disease,
41 septicemia in humans, secretes a PFT called V. vulnificus hemolysin (VVH), which contains a single C
42 hages were effective against three different V. vulnificus strains with various degrees of virulence,
44 road exopeptidase activity which may enhance V. vulnificus invasiveness by altering peptides involved
45 tant, containing the transposon and flanking V. vulnificus DNA was cloned, and a probe complementary
49 n of fatty acid metabolism are essential for V. vulnificus to be able to cause disease in mammalian h
51 Using the rat, we have developed a model for V. vulnificus endotoxic shock that mimics the sexually d
52 The effector domain region was required for V. vulnificus to inhibit phagocytosis by J774 macrophage
54 , TcdA, TcnA, and TcsL; putative toxins from V. vulnificus, Yersinia sp., Photorhabdus sp., and Xenor
55 ransport genes are regulated by iron, and in V. vulnificus, transcriptional regulation by iron depend
57 hat a wide variety of capsular carbotypes in V. vulnificus may be readily distinguished by the HPAE f
58 ociated with both CPS and rEPS expression in V. vulnificus, designated the wcr (capsular and rugose p
60 that the HlyU protein, a virulence factor in V. vulnificus CMCP6, up-regulates the expression of VV20
64 and the extracytoplasmic stress response in V. vulnificus, mutants with defined mutations in rseB an
68 onfirm that phase variation and virulence in V. vulnificus correlate with the amount of CPS expressed
71 experiments in a murine model of intravenous V. vulnificus infection demonstrated that expression of
72 ences in virulence among naturally occurring V. vulnificus can be explained by diverse abilities to r
74 Inactivation of pilA reduces the ability of V. vulnificus to form biofilms and significantly decreas
75 ed a genome-wide transcriptional analysis of V. vulnificus growing at three different iron concentrat
76 ar typing systems have shown associations of V. vulnificus genotypes and the environmental or clinica
81 cutaneously with 10 times the lethal dose of V. vulnificus and injected intravenously, either simulta
82 2 X 10(9) colony-forming unit (high dose) of V. vulnificus was administered through a mini-laparotomy
85 dicate that an important virulence factor of V. vulnificus is undergoing significant genetic rearrang
88 ines the growing international importance of V. vulnificus, particularly in the context of coastal wa
89 sertion mutagenesis in a clinical isolate of V. vulnificus to find genes necessary for virulence, and
90 olved to facilitate the aquatic lifestyle of V. vulnificus but that their emergence also resulted in
91 les are present on the lipopolysaccharide of V. vulnificus, are required for full motility and biofil
92 ge of human-derived peptides by PGI-LysAP of V. vulnificus using three approaches: (i) a quantitative
93 oculated iron dextran-treated mouse model of V. vulnificus disease, was hypersensitive to the fatty a
96 We previously constructed a fur mutant of V. vulnificus which constitutively expresses at least tw
98 variants and genetically defined mutants of V. vulnificus M06-24/O was examined by using a CPS-speci
102 hich may contribute both to pathogenicity of V. vulnificus and to its survival under adverse environm
103 ificantly reduced the virulence potential of V. vulnificus, while deletion of duf1 or abh accelerated
104 pulsed-field gel electrophoresis profiles of V. vulnificus strains isolated from blood and oysters as
110 saccharide of a related pathogenic strain of V. vulnificus (MO6-24) the structure of which was recent
111 accharide purified from a virulent strain of V. vulnificus 6353 did not show cross reactivity with an
114 pimerase is common to at least 10 strains of V. vulnificus that each express a serologically distinct
115 lar polysaccharides of pathogenic strains of V. vulnificus, there are distinct differences in the det
120 asize the importance of CPS for virulence of V. vulnificus and establish a correlation between CPS ex
121 nd septicemia in humans and the virulence of V. vulnificus has been strongly associated with encapsul
122 ng that in addition to capsule, virulence of V. vulnificus requires type IV pili and/or extracellular
123 mes cannot strictly predict the virulence of V. vulnificus strains and further investigation is neede
127 ted Vibrio species were V. parahaemolyticus, V. vulnificus, and V. alginolyticus; both surveillance s
131 prevalence of total Vibrio parahaemolyticus, V. vulnificus and V. cholerae and select genes associate
135 ated with human infections and that a single V. vulnificus strain, evidenced by pulsed-field gel elec
138 d that V. sinaloensis grew more rapidly than V. vulnificus in seawater at temperatures </= 30 degrees
143 ence of the 77-kDa protein purified from the V. vulnificus fur mutant had 67% homology with the first
146 as part of all N-glycans correlates with the V. vulnificus MARTX toxin having broad specificity and t
147 ablished that the MARTXVv toxin is linked to V. vulnificus dependent induction of apoptosis, but the
148 tood; however, its phenotypic resemblance to V. vulnificus and the possibility that it could outcompe
149 ecrosis factor alpha elicited in response to V. vulnificus and measured in cell supernatants were not
154 t common rtxA1 gene variant in clinical-type V. vulnificus encodes a toxin with reduced potency and i
155 terface wildfire ashes on Vibrio vulnificus (V. vulnificus) growth and gene expression using transcri
157 ntly enhances survival of mice infected with V. vulnificus by alleviating hepatic and renal dysfuncti